Literature DB >> 19957242

Inhibitory effect of quercetin on periodontal pathogens in vitro.

F Geoghegan1, R W K Wong, A B M Rabie.   

Abstract

Actinobacillus actinomycetemcomitans (Aa) and Porphyromonas gingivalis (Pg) are bacteria strongly associated with early onset, progressive and refractory periodontal disease and associated alveolar bone loss. Quercetin is a flavonoid found in many foods including apples, onions and tea. The aim of this study was to evaluate the effect of quercetin on in vitro growth of periodontal pathogens Aa and Pg. For comparison, quercetin's effect on several oral microbes was also evaluated. Different concentrations of quercetin solution were added to calibrated suspensions of Aa and Pg. All suspensions were incubated for 1, 3, 6, and 24 h in an anaerobic chamber at 37 degrees C. At each time point, selected dilutions from each culture broth were plated on blood agar plates. Colonies appearing on blood agar plates were visually counted on 3 days for Aa and 5 days for Pg. Minimum inhibitory concentrations of both periodontal pathogens were also determined. Both periodontal bacteria showed a significant decrease (p < 0.05) in viable counts after 1 h. No colony forming units of Pg could be observed after 24 h. The results suggest that quercetin possesses significant antimicrobial properties on periodontal pathogens in vitro. (c) 2009 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19957242     DOI: 10.1002/ptr.3014

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  11 in total

Review 1.  Quercetin: Its Main Pharmacological Activity and Potential Application in Clinical Medicine.

Authors:  Dengyu Yang; Tiancheng Wang; Miao Long; Peng Li
Journal:  Oxid Med Cell Longev       Date:  2020-12-30       Impact factor: 6.543

2.  Radical-scavenging and Pro-/anti-inflammatory Activity of Tetracycline and Related Phenolic Compounds With or Without Visible Light Irradiation.

Authors:  Yukio Murakami; Akifumi Kawata; Seiji Suzuki; Seiichiro Fujisawa
Journal:  In Vivo       Date:  2020 Jan-Feb       Impact factor: 2.155

Review 3.  Non-Nutrient, Naturally Occurring Phenolic Compounds with Antioxidant Activity for the Prevention and Treatment of Periodontal Diseases.

Authors:  Alfonso Varela-López; Pedro Bullón; Francesca Giampieri; José L Quiles
Journal:  Antioxidants (Basel)       Date:  2015-06-24

Review 4.  Psidium guajava: A review on its potential as an adjunct in treating periodontal disease.

Authors:  K Ravi; P Divyashree
Journal:  Pharmacogn Rev       Date:  2014-07

5.  In Vitro Antioxidant versus Metal Ion Chelating Properties of Flavonoids: A Structure-Activity Investigation.

Authors:  Sabri Ahmed Cherrak; Nassima Mokhtari-Soulimane; Farid Berroukeche; Bachir Bensenane; Angéline Cherbonnel; Hafida Merzouk; Mourad Elhabiri
Journal:  PLoS One       Date:  2016-10-27       Impact factor: 3.240

6.  Localized In Situ Nanoemulgel Drug Delivery System of Quercetin for Periodontitis: Development and Computational Simulations.

Authors:  Gururaj C Aithal; Usha Yogendra Nayak; Chetan Mehta; Reema Narayan; Pratibha Gopalkrishna; Sudharsan Pandiyan; Sanjay Garg
Journal:  Molecules       Date:  2018-06-06       Impact factor: 4.411

Review 7.  Antioxidant Activity of Spices and Their Impact on Human Health: A Review.

Authors:  Alexander Yashin; Yakov Yashin; Xiaoyan Xia; Boris Nemzer
Journal:  Antioxidants (Basel)       Date:  2017-09-15

8.  Quercetin Inhibits Cell Survival and Metastatic Ability via the EMT-mediated Pathway in Oral Squamous Cell Carcinoma.

Authors:  So Ra Kim; Eun Young Lee; Da Jeong Kim; Hye Jung Kim; Hae Ryoun Park
Journal:  Molecules       Date:  2020-02-10       Impact factor: 4.411

Review 9.  Nanoemulsions for health, food, and cosmetics: a review.

Authors:  Tolulope Joshua Ashaolu
Journal:  Environ Chem Lett       Date:  2021-03-15       Impact factor: 9.027

10.  Evaluation of a mouthrinse containing guava leaf extract as part of comprehensive oral care regimen- a randomized placebo-controlled clinical trial.

Authors:  Namratha Nayak; Jothi Varghese; Seema Shetty; Vinutha Bhat; Tejal Durgekar; Richard Lobo; Usha Y Nayak; Vishwanath U
Journal:  BMC Complement Altern Med       Date:  2019-11-21       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.